spiperone has been researched along with (3-iodobenzyl)trozamicol in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Efange, SM; Khare, AB; Langason, RB; Low, WC | 1 |
1 other study(ies) available for spiperone and (3-iodobenzyl)trozamicol
| Article | Year |
|---|---|
The vesamicol receptor ligand (+)-meta-[125I]iodobenzyltrozamicol [(+)-[125I]-MIBT] reveals blunting of the striatal cholinergic response to dopamine D2 receptor blockade in the 6-hydroxydopamine (6-OHDA)-lesioned rat: possible implications for Parkinson'
Topics: Animals; Brain Diseases; Cholinergic Fibers; Corpus Striatum; Disease Models, Animal; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Iodine Radioisotopes; Iodobenzenes; Ligands; Male; Oxidopamine; Parkinson Disease; Piperidines; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Cholinergic; Spiperone | 1996 |